1.35 million babies are born with a congenital heart defect each year. Of these, 400,000 have heart valve defects but there is no durable valve replacement on the market. GrOwnValve aims to fulfill that unmet clinical need.
GrOwnValve is a pre-clinical stage medical device company, developing a unique heart valve prosthesis system. Their completely new prosthetic valve for adults and children, will be implanted using a low-risk transcatheter technique.
The valves will come to market as a procedure pack that enables a safe, affordable and easy-to-use minimally invasive heart valve replacement made from the patient’s own tissue. Using the patient’s own endogenous tissue gives the valves lifelong durability – a once-in-a-lifetime solution that is affordable for patients and healthcare providers worldwide.
Dr. Boris Schmitt is the CEO and Co-Founder of GrOwnValve. He is a Pediatric Cardiologist and a Senior Consultant at Charité University Medicine Berlin.
To learn more visit https://www.grownvalve.com/
For questions or comments, please email us at info@inam.berlin. Also, if you or someone you know would like to be a guest on our show, we welcome any and all suggestions!